<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Scholar Rock price target lowered to $44 from $50 at H.C. Wainwright

PremiumThe Fly

4d ago

Scholar Rock receives CRL from FDA for apitegromab BLA

SRRK

PremiumThe Fly

4d ago

Mixed options sentiment in Novo Nordisk with shares down 0.86%

SRRK

PremiumThe Fly

5d ago

Bristol Myers commitment a reminder of Veeva’s progress, says Stifel

PremiumThe Fly

5d ago

BMY

GSK

PremiumThe FlyWalmart to deliver refrigerated prescriptions, including Ozempic, Bloomberg says

5d ago

WMT

Novo Nordisk falling forecasts slim Denmark’s economic growth, NYT says

The Fly

Novo Nordisk falling forecasts slim Denmark’s economic growth, NYT says

5d ago

Cautious Outlook for Novo Nordisk Amid Uncertain Pipeline Outcomes and Growth Challenges

Ratings

Cautious Outlook for Novo Nordisk Amid Uncertain Pipeline Outcomes and Growth Challenges

8d ago

Novo Nordisk cut obesity education sales team, Reuters says

PremiumThe Fly

9d ago

Morning Movers: Intel jumps following $5B investment from Nvidia

PremiumThe Fly

9d ago

DRI

PremiumThe Fly

Novo Nordisk publishes results from OASIS 4 trial of Wegovy in NEJM

9d ago

Novo Nordisk upgraded to Buy from Hold at Berenberg

PremiumThe Fly

10d ago

PremiumThe FlyFDA sends Novo Nordisk warning letter over weight loss video

11d ago

Morning Movers: New York Times slips following $15B lawsuit from President Trump

The Fly

Morning Movers: New York Times slips following $15B lawsuit from President Trump

11d ago

CMG

DIS

Novo Nordisk reports cagrilintide provided average weight reduction of 11.8%

The Fly

Novo Nordisk reports cagrilintide provided average weight reduction of 11.8%

11d ago

Novo Nordisk to seek U.S. approval for high-dose obesity shot, Bloomberg reports

PremiumThe Fly

11d ago

Novo Nordisk upgraded to Buy from Neutral at Rothschild & Co Redburn

PremiumThe Fly

11d ago

Novo Nordisk announced results from INFORM survey on semaglutide

PremiumThe Fly

11d ago

Novo looks to broaden options, stay competitive in weight-loss space, FT says

PremiumThe Fly

12d ago

PremiumThe FlyMixed options sentiment in Novo Nordisk with shares up 1.15%

15d ago

Microsoft, OpenAI sign MOU for next phase of partnership: Morning Buzz

The Fly

Microsoft, OpenAI sign MOU for next phase of partnership: Morning Buzz

15d ago

Novo Nordisk tells workers to return to office, Bloomberg reports

The Fly

Novo Nordisk tells workers to return to office, Bloomberg reports

15d ago